Caribou is pulling the plug on its allogeneic CAR-T programs — vispa-cel and CB-011 are done — and says it will explore strategic alternatives, up to and including a sale of the company or its assets.
Caribou halts CAR-T programs and explores strategic alternatives, signaling major pipeline setback.
CRBU
$0.46
-2.11%
What changed
Caribou halts CAR-T programs and explores strategic alternatives, signaling major pipeline setback.
Why it matters
Caribou halts CAR-T programs and explores strategic alternatives, signaling major pipeline setback. — impact context not separately stored; see What changed.
← Dashboard
Oct 06, 2026 08:28 PM ET